Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Shapiro, MD
Intercept Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Joseph'S Hospital and Medical Center
Phoenix, Arizona, United States
- Scripps Clinic
La Jolla, California, United States
- Inland Empire Liver Foundation
Rialto, California, United States
- Nature Coast Clinical Research
Inverness, Florida, United States
- University of Miamai, Schiff Center for Liver Diseases
Miami, Florida, United States
- South Florida Center of Gastroenterology
Wellington, Florida, United States
- Florida Medical Clinic, P.A.
Zephyrhills, Florida, United States
- the Queen'S Medical Center - Liver Center
Honolulu, Hawaii, United States
- Mercy Medical Center, Institute for Digestive Health & Liver Disease
Baltimore, Maryland, United States
- Kansas City Research Institute
Kansas City, Missouri, United States
- St. Louis University
St Louis, Missouri, United States
- Duke University Medical Center
Durham, North Carolina, United States
- Cumberland Research Associates, Llc
Fayetteville, North Carolina, United States
- Consultants for Clinical Research
Cincinnati, Ohio, United States
- Thomas Jefferson University
Philadelphia, Pennsylvania, United States
- University Gastroenterology Liver Center
Providence, Rhode Island, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Clinsearch
Chattanooga, Tennessee, United States
- Texas Clinical Research Institute, Llc
Arlington, Texas, United States
- Liver Associates of Texas, P.A.
Houston, Texas, United States
- American Research Corporation at the Texas Liver Institute
San Antonio, Texas, United States
- Mcguire Dvamc
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Dec 2015
- Primary completion
- 21 Mar 2017
- Completion
- 12 Mar 2018
- Last update posted
- 4 Jun 2018
- Registered enrollment
- 84
- Registry id
- NCT02633956
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.